FlightPlan for Embolization is an AI-enabled medical device from GE Medical Systems SCS, listed by FDA (510(k), K223490) with a decision date of 2023-03-21. Review panel: Radiology.
| FDA submission number | K223490 |
|---|---|
| Pathway | 510(k) |
| Company | GE Medical Systems SCS |
| Review panel (specialty) | Radiology |
| FDA decision date | 2023-03-21 |
| Decision | Substantially Equivalent |
| Product code | LLZ |
| Classification | System, Image Processing, Radiological |
| Device class | 2 |
| Regulation number | 892.2050 |
| Review time (calendar days) | 120 |
| Applicant country | FR |
Official FDA database record · FDA AI-enabled device list
More devices from GE Medical Systems SCS · All Radiology AI devices · Full device index
Data from FDA's AI-enabled device list and openFDA. Informational only; verify against the FDA record.